 |
|
treosulfan
The prodrug of a bifunctional sulfonate alkylating agent with myeloablative, immunosuppresive, and antineoplastic activities. Under physiological conditions, treosulfan converts nonenzymatically to L-diepoxybutane via a monoepoxide intermediate. The monoepoxide intermediate and L-diepoxybutane alkylate DNA at guanine residues and produce DNA interstrand crosslinks, resulting in DNA fragmentation and apoptosis. In escalated doses, this agent also exhbits myeloablative and immunosuppressive activities. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
| Synonyms: | | dihydroxybusulfan
treosulphan
tresulfon | | | | Foreign brand name: | | Ovastat | | | | Chemical structure names: | | - (S-(R*,R*))-1,2,3,4-butanetetrol,1,4-dimethanesulfonate
- L-threitol 1,4-dimethanesulfonate
| | |
|
|
